USPTO 2015–2025 USPTO PatentsView US Corporation

Auris Health, Inc.

USPTO PatentsView assignee record — 387 granted patents across 25 technology areas, active 2018–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

387
Total patents granted
25
CPC technology areas
19.9
Avg claims per patent
+590%
5-year filing velocity

Portfolio overview

Auris Health, Inc. has been granted 387 US utility patents between 2018 and 2025, placing Auris Health, Inc. at rank #1,102 across all assignees tracked by PlainPatent. This portfolio spans 25 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.9 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Auris Health, Inc. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 59.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 338 grants, compared with 49 in the 2015–2019 window — a +590% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Auris Health, Inc.'s 19.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 25 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Auris Health, Inc. against peers pursuing similar technology classes.

How does Auris compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Auris holds 387 patents — placing it at rank #1,102 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2018–2025

020406080 20182019202020212022202320242025 61
USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table
Auris Health, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2018 16 4.1%
2019 33 8.5%
2020 53 13.7%
2021 42 10.9%
2022 50 12.9%
2023 60 15.5%
2024 72 18.6%
2025 61 15.8%

Which technologies does Auris Health, Inc. patent most?

Top 15 of 25 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Accelerating

Where it ranks

Overall rank by patents

#1,102

Across all tracked assignees

Innovation Score

59.7 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Auris Health, Inc. hold?
Auris Health, Inc. holds 387 US granted patents filed between 2018 and 2025, spanning 25 technology areas.
What is Auris Health, Inc.'s Innovation Score?
Auris Health, Inc. has an Innovation Score of 59.7 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Auris Health, Inc. focus on?
Auris Health, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 350 patents. The company has filed patents in 25 CPC subclasses total.
Is Auris Health, Inc.'s patent filing rate increasing or decreasing?
Auris Health, Inc.'s recent filing velocity is +590% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Auris Health, Inc.'s patents?
Auris Health, Inc.'s patents average 19.9 claims each. This falls within the standard range, providing solid legal coverage.
How is the Auris Health, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope